Joint Corp

Joint Corp (JYNT) Stock Analysis

$7.370

-0.137 (-1.86%)At close

Loading chart…
High
7.630
Open
7.510
VWAP
7.46
Volume
59.83K
Mkt Cap
204.84M
Low
7.370
Amount
446.12K
EV/EBITDA, TTM
22.84

The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.

AI analysis of Joint Corp (JYNT)

Buy

Joint Corp (JYNT) is a good buy right now due to its current price of $7.32, which is significantly below its 52-week high of $10.67, indicating potential for upside. The gross margin has improved to 80.90%, showcasing strong profitability, while insider buying has surged by 24955.71%, indicating confidence from those within the company. However, the main risk is the recent earnings surprise of -109.09%, which could impact investor sentiment.

Analyst Ratings (3)

+53.73% upside
Buy
3 Buy
0 Hold
0 Sell
Current: 7.37
Low
9.00
Average
11.33
High
14.00

Roth Capital

2026-03-13

Price Target

$12

Buy

B. Riley

2025-11-07

Price Target

$9

Neutral

Lake Street

2025-11-07

Price Target

$11

Buy

Roth Capital

2025-11-07

Price Target

$14

Buy

Lake Street

2025-05-09

Price Target

$16

Buy

Valuation Metrics

The current forward P/E ratio for Joint Corp (JYNT) is 9.47, compared to its 5-year average forward P/E of 86.45.

Forward P/E

Fair
5Y Average P/E
86.45
Current P/E
9.47
Overvalued
182.44
Undervalued
-9.53

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
24.86
Current EV/EBITDA
22.84
Overvalued
48.14
Undervalued
1.58

Forward P/S

Fair
5Y Average P/S
2.52
Current P/S
1.70
Overvalued
4.51
Undervalued
0.52

Alphio AI Price Scenarios for JYNT

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%JYNT

$10.79

Scenario price

B

Base

Base · 50%JYNT

$9.39

Scenario price

B

Bear

Bear · 25%JYNT

$8.24

Scenario price

Events Timeline

2026-11-05 (ET)

17:30:00

The Joint Increases Stock Repurchase Authorization by $5 Million

17:30:00

The Joint Corp. Reports Q3 Revenue of $13.55M

2026-08-06 (ET)

17:30:00

The Joint Corp. Reports Q2 Revenue of $15.18M

17:30:00

Company Expects System-wide Sales Between $519 Million and $552 Million

2026-05-07 (ET)

17:30:00

The Joint Corp. Q1 Revenue $14.82M, Exceeds Expectations

News

JYNT FAQ — answered by Alphio AI

The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations. It operates in the Healthcare sector (PATENT OWNERS & LESSORS industry).

Joint Corp (JYNT) is a good buy right now due to its current price of $7.32, which is significantly below its 52-week high of $10.67, indicating potential for upside. The gross margin has improved to 80.90%, showcasing strong profitability, while insider buying has surged by 24955.71%, indicating confidence from those within the company. However, the main risk is the recent earnings surprise of -109.09%, which could impact investor sentiment.

3 analysts cover JYNT: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 11.33.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading